![The Asian Pacific Association for the Study of the Liver [APASL]](http://apasl.info/app-def/S-102/apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}
APASL Hepatology Webinar 5-9 has been successfully held!
Invitation to APASL Hepatology Webinar
Friday, December 17th 2021 at 20:00-22:00
(Japan Standard Time= +9:00 GMT)
It is our great pleasure to invite you to participate in the Asian Pacific Association for the Study of Liver (APASL) Hepatology Webinar Episode 5.
Please don’t miss it!
Register at: https://regconf.com/apasl_webinar/
APASL 2022 SEOUL
We would like to thank all the authors who submitted their valuable abstracts to the APASL 2022 SEOUL. As many potential authors have requested an extension of the abstract submission date, we have decided to extend the abstract submission deadline to November 25(Thu.),2021. So, do not miss this chance and submit your abstract today!
APASL Hepatology webinar
The previous sessions of APASL Hepatology Webinar have been uploaded at APASL Official YouTube.
Please subscribe to our APASL channel!
APASL Official YouTube: URL
APASL COVID-19 Hepatology Task Force has published clinical practice guidance!
You can read and download the guidance from This PAGE.
May 15, 2020
Dear Colleagues,
“We need hope but not false hope”
NEVER in the history of mankind should we be more united to confront a common deadly enemy-Covid-19. To win this war for human race, we need knowledge from at all fronts, be united for critical thinking and there should be no room for finger-pointing. Without immunity and any highly effective treatment, we can only anticipate more casualties directly or indirectly from COVID-19. So far, tremendous effort has been exercised to control new human transmission by social isolation and quarantine. However, this can only “flatten but not to eliminate the curve”. The cost of these measures is also tremendous making life. especially in the lower social sector, intolerable. We need to figure out a better solution to prevent and to treat COVID-19, as it is unlikely to go away shortly. On the other hand, we also need to have people back to work or to schooling safely. To this end, we have organized a series of webinar with experts in various field to enlightened us the most recent Asia-Pacific data in epidemiology, diagnostic test, treatment and measures to control infection transmission and fatality rate.
We look forward to your participation!
Yours sincerely
Masao Omata MD / George Lau MD
Conveners of APASL COVID-19 Taskforce
Bronze Sponsor
Sponsor
APASL Annual Meeting 2022 in Seoul
The next APASL Annual Meeting will be held in Seoul!
The abstract submission process has been opened. Please check the link below.
https://apasl2022seoul.org/newsletter/mail_211001_10th.php
Future Meetings
APASL Annual Meeting in Korea
Date: March 30-April 3, 2022 City: COEX, Seoul, Korea President: Dr. Jin Mo Yang Website: http://www.apasl2022seoul.org/ |
 |
APASL STC on Liver Fibrosis
Date: May, 2022 City: Beijing, China President: Dr. Hong You Website: to be announced. |
APASL STC on Advances in the Prevention and Management of Liver Cirrhosis and Its Complication
Date: October 14-16, 2022 City: Manila, Philippines President: Dr. Ian Homer Y. Cua Website: to be announced. |
APASL STC on Liver Fibrosis: APASL Consensus Update
Date: June, 2022 City: Cairo, Egypt President: Dr. Gamal Shiha Website: to be announced. |
APASL STC on Paradigm Shift of HCC Management: Across Viral to Steatogenic Carcinogenesis
Date: June 23-25, 2022 City: NTUH International Convention Center, Taiwan, Taipei President: Dr. Chun-Jen Liu Website: to be announced. |
 |
HCC：Clinical and basic research
Date: September 1-3, 2022 City: Takamatsu, Japan President: Dr. Tsutomu Masaki |
 |
APASL STC on Critical Care in Hepatology: ACLF
Date: September 16-18, 2022 City: Wuhan, China President: Dr. Qin Ning Website: http://www.apaslstc2021wh.com |
 |
APASL STC on NAFLD/NASH: Non-Infection Epidemic in XXI
Date: October 8-10, 2022 City: Yerevan, Armenia President: Dr. Hasmik Ghazinian Website: to be announced. |
 |
APASL STC on Image-guided Interventions in Liver Diseases
Date: November, 2022 City: Guangzhou, China President: Dr. Jinjun Chen Website: to be announced. |
APASL STC on Hepatotoxicity
Date: September 23-25, 2022 City: Istanbul, Turkey President: Dr. İbrahim Halil Bahcecioglu Website: to be announced. |
APASL Annual Meeting 2023
Date: March, 2023 City: Taipei, Taiwan President: Dr. Han-Chieh Lin Website: to be announced. |
APASL Oncology 2023
Date: Spring/Autumn 2023 City: Sendai, Japan President: Dr. Yoshiyuki Ueno Website: to be announced. |
APASL Guidelines
The Guideline written by Dr. T Kanda has been published!
APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HBV -"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update" (Hepatol Int 2016; 10:1–98)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int 2016 10:681–701)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int 2016 10:702–726)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)
*This APASL Guideline can be downloaded by clicking below.
APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017 11:1–30)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)
*This APASL Guideline can be downloaded by clicking below.